Skip to main content

Protecting children with life-saving packaging

Current and future child-resistant packaging trends in the pharma industry.

 

SGD Pharma continues customer-led innovation with range extension for Sterinity Ready-to-Use molded glass vials: adds amber 50ml size ISO and EasyLyo in Tray

Puteaux Cedex, FRANCE – 8th April 2021: Worldwide glass primary packaging supplier SGD Pharma announces the continued expansion of its Ready-to-Use (RTU) Sterinity molded glass vial platform with the introduction of amber glass 50ml volume option in Tray, now available ex-stock.

 

Webinar - Ready-to-use primary packaging for flexible aseptic operations

Webinar - Why pharma packaging choice matters in protecting children's lives ?

Sucy-en-Brie plant celebrated the first furnace lighting ceremony in 10 years

Sucy-en-Brie plant celebrated the first furnace lighting ceremony in 10 years – the result of weeks of hard work modernizing the furnace as part of SGD Pharma’s Sucy Pharma 2025 project.

Key milestone in molded glass: SGD Pharma elevates Type I offering with three tailored product and service solutions

Strengthened value propositions represent the latest step in SGD Pharma’s commitment to continuous improvement

COVID-19 Container Closure System and Component Changes: Glass Vials and Stoppers

Guidance for Industry - March 2021

This guidance represents the current thinking of the Food and Drug Administration (FDA or Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it satisfies the requirements of the applicable statutes and regulations. To discuss an alternative approach, contact the FDA staff or Office responsible for this guidance as listed on the title page.

Covid-19 Vaccines : vaccines and mass production

Covid-19 Vaccines : vaccines and mass production

Source: The Pharmaceutical Post n°05 - February 2021

After the moment of truth as to their effectiveness, time has come for large-scale production to pass this test, which is something new, especially for messenger RNA-based vaccines.

Molded Vial Manufacturing and Its Impact on Heat Transfer during Freeze-Drying: Vial Geometry Considerations

Molded Vial Manufacturing and Its Impact on Heat Transfer during Freeze-Drying: Vial Geometry Considerations

 

Authors:​ Tim Wenzel & Henning Gieseler - ​AAPS PharmSciTech​ - 27/01/2021 - DOI 10.1208/s12249-021-01926-x

 

Subscribe to